Slides on Medical Minute 1: Endogenous Incretins

Learn about endogenous incretins, their downstream effects, and role in type 2 diabetes.
Carol Hatch Wysham, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.12 MB
Released: August 9, 2021

Acknowledgements

Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by an educational grant from
Lilly

Related Content

Expert commentary on the use of diabetes technologies in pediatric patients, from Jennifer Sherr, MD, PhD, and Clinical Care Options (CCO)

Jennifer Sherr, MD, PhD Released: January 14, 2022

Expert commentary by Dr Mark S. Sulkowski on the importance of investigating elevated liver enzymes in patients with HIV, from Clinical Care Options (CCO)

Mark S. Sulkowski, MD Released: January 10, 2022

Interactive video on current and emerging digital technology to help better manage patients on insulin therapy

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Anne Peters, MD Jennifer Sherr, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Registered Dietitians/Dietetic Technicians, Registered: maximum of 1.0 CPEU(s) Released: November 12, 2021 Expired: November 11, 2022

CCO slides: current and emerging digital technology to help better manage patients on insulin therapy.

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Anne Peters, MD Jennifer Sherr, MD, PhD Released: November 12, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings